Monness Crespi & Hardt Issues Pessimistic Forecast for Crocs (NASDAQ:CROX) Stock Price

Crocs (NASDAQ:CROX) had its price objective lowered by Monness Crespi & Hardt from $170.00 to $140.00 in a research report report published on Wednesday morning, MarketBeat.com reports. Monness Crespi & Hardt currently has a buy rating on the textile maker’s stock.

A number of other research analysts have also recently commented on the stock. UBS Group reduced their target price on shares of Crocs from $148.00 to $146.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 16th. Raymond James cut Crocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Guggenheim assumed coverage on Crocs in a research report on Wednesday, October 9th. They issued a “buy” rating and a $182.00 target price on the stock. Barclays decreased their price target on shares of Crocs from $164.00 to $125.00 and set an “overweight” rating for the company in a research report on Tuesday. Finally, KeyCorp upped their price target on shares of Crocs from $149.00 to $155.00 and gave the company an “overweight” rating in a report on Thursday, September 26th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Crocs currently has a consensus rating of “Moderate Buy” and a consensus target price of $154.00.

Crocs Stock Performance

NASDAQ CROX opened at $106.21 on Wednesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.43 and a quick ratio of 0.95. Crocs has a 1-year low of $74.00 and a 1-year high of $165.32. The firm has a market capitalization of $6.19 billion, a P/E ratio of 7.70, a P/E/G ratio of 1.10 and a beta of 2.01. The business’s 50-day simple moving average is $135.60 and its 200-day simple moving average is $138.11.

Crocs (NASDAQ:CROX) last released its quarterly earnings data on Tuesday, October 29th. The textile maker reported $3.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.10 by $0.50. Crocs had a net margin of 20.50% and a return on equity of 49.70%. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the prior year, the business earned $3.25 earnings per share. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. Equities analysts predict that Crocs will post 12.94 EPS for the current year.

Insider Transactions at Crocs

In related news, Director Douglas J. Treff sold 10,594 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the transaction, the director now owns 81,254 shares in the company, valued at $10,756,404.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total value of $1,402,433.72. Following the sale, the director now directly owns 81,254 shares in the company, valued at approximately $10,756,404.52. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John B. Replogle acquired 2,240 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was purchased at an average cost of $112.60 per share, for a total transaction of $252,224.00. Following the acquisition, the director now owns 9,304 shares in the company, valued at approximately $1,047,630.40. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Institutional Investors Weigh In On Crocs

Several institutional investors have recently bought and sold shares of the stock. Financial Management Professionals Inc. increased its stake in shares of Crocs by 11,200.0% during the third quarter. Financial Management Professionals Inc. now owns 226 shares of the textile maker’s stock valued at $33,000 after acquiring an additional 224 shares during the period. GHP Investment Advisors Inc. grew its position in Crocs by 375.0% in the second quarter. GHP Investment Advisors Inc. now owns 228 shares of the textile maker’s stock worth $33,000 after buying an additional 180 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of Crocs by 64.9% in the third quarter. UMB Bank n.a. now owns 305 shares of the textile maker’s stock valued at $44,000 after buying an additional 120 shares in the last quarter. V Square Quantitative Management LLC lifted its position in shares of Crocs by 83.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 313 shares of the textile maker’s stock valued at $45,000 after acquiring an additional 142 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in shares of Crocs by 19.3% during the 2nd quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock worth $144,000 after acquiring an additional 162 shares in the last quarter. Institutional investors and hedge funds own 93.44% of the company’s stock.

Crocs Company Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.